https://www.ema.europa.eu/en/homepagePaediatric investigation plansen-gbCopyright: (C) European Medicines AgencyFri, 10 May 2024 03:35:06 +0200Fri, 03 May 2024 16:26:00 +0200https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-002754-pip01-19EMEA-002754-PIP01-19https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-002754-pip01-19Fri, 03 May 2024 16:26:00 +0200Paediatric investigation planshttps://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-002693-pip01-19EMEA-002693-PIP01-19https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-002693-pip01-19Fri, 03 May 2024 16:18:00 +0200Paediatric investigation planshttps://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-003157-pip01-21EMEA-003157-PIP01-21https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-003157-pip01-21Fri, 03 May 2024 16:14:00 +0200Paediatric investigation planshttps://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001666-pip01-14-m01EMEA-001666-PIP01-14-M01https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001666-pip01-14-m01Fri, 03 May 2024 16:08:00 +0200Paediatric investigation planshttps://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-002981-pip01-21EMEA-002981-PIP01-21https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-002981-pip01-21Wed, 17 Apr 2024 15:30:00 +0200Paediatric investigation planshttps://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000727-pip01-09-m07Opinion/decision on a Paediatric investigation plan (PIP): Bosulif, Bosutinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0336/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000727-pip01-09-m07Thu, 11 Apr 2024 16:21:00 +0200Paediatric investigation plans